Search Results - "Zhang, Erbao"

Refine Results
  1. 1

    The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma by Qiu, Mantang, Xia, Wenjia, Chen, Rui, Wang, Siwei, Xu, Youtao, Ma, Zhifei, Xu, Weizhang, Zhang, Erbao, Wang, Jie, Fang, Tian, Hu, Jingwen, Dong, Gaochao, Yin, Rong, Wang, Jun, Xu, Lin

    Published in Cancer research (Chicago, Ill.) (01-06-2018)
    “…Somatic copy number variations (CNV) may drive cancer progression through both coding and noncoding transcripts. However, noncoding transcripts resulting from…”
    Get full text
    Journal Article
  2. 2

    A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1 by Zhang, Erbao, He, Xuezhi, Zhang, Chongguo, Su, Jun, Lu, Xiyi, Si, Xinxin, Chen, Jinfei, Yin, Dandan, Han, Liang, De, Wei

    Published in Genome Biology (04-10-2018)
    “…Recently, increasing evidence shows that long noncoding RNAs (lncRNAs) play a significant role in human tumorigenesis. However, the function of lncRNAs in…”
    Get full text
    Journal Article
  3. 3

    LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer by Dai, Jiali, Qu, Tianyu, Yin, Dandan, Cui, Yanan, Zhang, Chen, Zhang, Erbao, Guo, Renhua

    Published in Cell death & disease (08-05-2023)
    “…Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment prolongs the survival of lung cancer patients harbouring activating EGFR…”
    Get full text
    Journal Article
  4. 4

    H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma by Zhang, Erbao, Han, Liang, Yin, Dandan, He, Xuezhi, Hong, Linzhi, Si, Xinxin, Qiu, Mantang, Xu, Tongpeng, De, Wei, Xu, Lin, Shu, Yongqian, Chen, Jinfei

    Published in Nucleic acids research (07-04-2017)
    “…Recently, long non-coding RNAs (lncRNAs) have been shown to have important regulatory roles in human cancer biology. In our study, we found that lncRNA CCAT1,…”
    Get full text
    Journal Article
  5. 5

    Roles of RNA methylation by means of N6-methyladenosine (m6A) in human cancers by Wang, Siwei, Sun, Chunxiao, Li, Jianhua, Zhang, Erbao, Ma, Zhifei, Xu, Weizhang, Li, Hong, Qiu, Mantang, Xu, Youtao, Xia, Wenjia, Xu, Lin, Yin, Rong

    Published in Cancer letters (01-11-2017)
    “…Reversible methylation by means of N6-methyladenosine (m6A) is the most prevalent internal modification in mammalian mRNA. This RNA chemical mark is created by…”
    Get full text
    Journal Article
  6. 6

    Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression by Yin, Dandan, Lu, Xiyi, Su, Jun, He, Xuezhi, De, Wei, Yang, Jinsong, Li, Wei, Han, Liang, Zhang, Erbao

    Published in Molecular cancer (24-05-2018)
    “…Mounting evidence indicates that long noncoding RNAs (lncRNAs) could play a pivotal role in cancer biology. However, the role and molecular mechanism and…”
    Get full text
    Journal Article
  7. 7

    C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation by Zhao, Chenhui, Li, Yongting, Qiu, Wen, He, Fengxia, Zhang, Weiming, Zhao, Dan, Zhang, Zhiwei, Zhang, Erbao, Ma, Pei, Liu, Yiqian, Ma, Ling, Yang, Fengming, Wang, Yingwei, Shu, Yongqian

    Published in Oncogene (01-08-2018)
    “…Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, and multiple evidence has confirmed that C5a production is elevated in NSCLC…”
    Get full text
    Journal Article
  8. 8

    B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma by Cui, Yanan, Li, Jun, Zhang, Pengpeng, Yin, Dandan, Wang, Ziyu, Dai, Jiali, Wang, Wei, Zhang, Erbao, Guo, Renhua

    “…Invasive adenocarcinoma (IAC), which is typically preceded by minimally invasive adenocarcinoma (MIA), is the dominant pathological subtype of early-stage lung…”
    Get full text
    Journal Article
  9. 9
  10. 10

    c-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer by Zhang, Erbao, Li, Wei, Yin, Dandan, De, Wei, Zhu, Liangjun, Sun, Sanyuan, Han, Liang

    Published in Tumor biology (01-03-2016)
    “…Recently, long non-coding RNAs (lncRNAs) have been shown to play important roles in human cancer biology. The purpose of this study was to assess the…”
    Get full text
    Journal Article
  11. 11

    Gene Amplification-Driven Long Noncoding RNA SNHG17 Regulates Cell Proliferation and Migration in Human Non-Small-Cell Lung Cancer by Xu, Tianwei, Yan, Shuai, Jiang, Lihua, Yu, Shanxun, Lei, Tianyao, Yang, Daolu, Lu, Binbin, Wei, Chenchen, Zhang, Erbao, Wang, Zhaoxia

    Published in Molecular therapy. Nucleic acids (06-09-2019)
    “…Lung cancer is the most common cancer all around the world, with high morbidity and mortality. Long noncoding RNA (lncRNA) has been reported to have a critical…”
    Get full text
    Journal Article
  12. 12

    lncRNA UCA1 Predicts a Poor Prognosis and Regulates Cell Proliferation and Migration by Repressing p21 and SPRY1 Expression in GC by He, Xuezhi, Wang, Jing, Chen, Jin, Han, Liang, Lu, Xiyi, Miao, Dengshun, Yin, Dandan, Geng, Qinghe, Zhang, Erbao

    Published in Molecular therapy. Nucleic acids (06-12-2019)
    “…Dysregulated expression of long non-coding RNAs (lncRNAs) has been reported in many types of cancers, indicating that it has important regulatory roles in…”
    Get full text
    Journal Article
  13. 13

    PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers by Dai, Jiali, Cui, Yanan, Liang, Xiao, Xu, Jiali, Li, Jun, Chen, Yu, Zhang, Erbao, Guo, Renhua

    Published in Frontiers in genetics (09-01-2023)
    “…There has been evidence that Polybromo-1 (PBRM1) mutation was closely associated with immunotherapy response in clear cell renal cell carcinoma (ccRCC)…”
    Get full text
    Journal Article
  14. 14

    Gene amplification-driven lncRNA SNHG6 promotes tumorigenesis via epigenetically suppressing p27 expression and regulating cell cycle in non–small cell lung cancer by Wang, Qi, Zhang, Wei, Yin, Dandan, Tang, Zaibin, Zhang, Erbao, Wu, Weibing

    Published in Cell death discovery (09-12-2022)
    “…Long non-coding RNAs (lncRNAs) have been validated to play essential roles in non-small cell lung carcinoma (NSCLC) progression. In this study, through…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Long noncoding RNA cytoskeleton regulator RNA promotes cell invasion and metastasis by titrating miR‐613 to regulate ANXA2 in nasopharyngeal carcinoma by Chen, Wei, Du, Mingyu, Hu, Xinyu, Ma, Hongxia, Zhang, Erbao, Wang, Tingting, Yin, Li, He, Xia, Hu, Zhibin

    Published in Cancer medicine (Malden, MA) (01-02-2020)
    “…Background Nasopharyngeal carcinoma (NPC) is one of the most frequent head and neck malignant tumors. Long noncoding RNAs play critical roles in tumorigenesis…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Multi-omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma by Huang, Qi, Chen, Haiming, Yin, Dandan, Wang, Jie, Wang, Shaodong, Yang, Feng, Li, Jiawei, Mu, Teng, Li, Jilun, Zhao, Jia, Yin, Rong, Li, Wei, Qiu, Mantang, Zhang, Erbao, Li, Xiangnan

    Published in NPJ precision oncology (30-01-2024)
    “…Metabolic reprogramming has been observed in cancer metastasis, whereas metabolic changes required for malignant cells during lymph node metastasis of…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR‐TKIs in advanced non‐small cell lung cancer: A systematic review and network meta‐analysis by Dai, Jiali, Liu, Xinyin, Li, Jun, Qu, Tianyu, Cui, Yanan, Jin, Shidai, Zhang, Erbao, Guo, Renhua

    Published in Thoracic cancer (01-02-2023)
    “…Background The combination of antiangiogenic agents with epidermal growth factor receptor inhibitors (EGFR‐TKIs) and chemotherapy with EGFR‐TKIs are the most…”
    Get full text
    Journal Article